Cargando…
Deep learning and virtual drug screening
Current drug development is still costly and slow given tremendous technological advancements in drug discovery and medicinal chemistry. Using machine learning (ML) to virtually screen compound libraries promises to fix this for generating drug leads more efficiently and accurately. Herein, we expla...
Autores principales: | Carpenter, Kristy A, Cohen, David S, Jarrell, Juliet T, Huang, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563286/ https://www.ncbi.nlm.nih.gov/pubmed/30288997 http://dx.doi.org/10.4155/fmc-2018-0314 |
Ejemplares similares
-
Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review
por: Carpenter, Kristy A., et al.
Publicado: (2018) -
Blockchain in Healthcare: A Patient-Centered Model
por: Chen, Hannah S, et al.
Publicado: (2019) -
Network Medicine for Alzheimer’s Disease and Traditional Chinese Medicine
por: Jarrell, Juliet T., et al.
Publicado: (2018) -
Identification and Analysis of Alzheimer’s Candidate Genes by an Amplitude Deviation Algorithm
por: Pang, Chaoyang, et al.
Publicado: (2019) -
Deep Learning in Virtual Screening: Recent Applications and Developments
por: Kimber, Talia B., et al.
Publicado: (2021)